Tranexamic Acid 100mg Injection Franchise for Bleeding Control in Mumbai Maharashtra

Tranexamic Acid Injection for Surgical & Gynecological Hemostasis in Delhi NCR

Tranexamic Acid 100mg Injection Hospital Supply Opportunity in Chennai Tamil Nadu

Tranexamic Acid Injection PCD Pharma Franchise in Kolkata West Bengal

High-Demand Antihemorrhagic Injection for Blood Loss Prevention in Bangalore Karnataka
Tranexamic Acid 100mg Injection B2B PCD Monopoly Opportunity in Hyderabad Telangana

Home/Products /tranexamic-acid-ip-100-mg-injection

About the Product

Description


Traxlink 100 Injection (Tranexamic Acid 100mg) is an antihemorrhagic and antifibrinolytic injection designed to prevent or control excessive bleeding in surgical, dental, or traumatic procedures. Tranexamic Acid works by inhibiting plasminogen activation, promoting clot stability and reducing blood loss.

It is widely prescribed by surgeons, gynecologists, and emergency care specialists, ensuring steady institutional and hospital demand. Traxlink 100 Injection provides a strong PCD pharma franchise opportunity ideal for B2B distribution, maTranexamic Acid 100 mg Injection – PCD Pharma Franchise Marketing Materialnufacturing, and export, serving the critical care and hemostatic therapy segment with reliability and profitability.

Common side effects include gastrointestinal disturbances, dizziness, and headaches; serious reactions are rare.

Traxlink ET Tablet is indicated for managing heavy menstrual bleeding and other types of excessive bleeding.

Use under medical supervision, particularly for pregnant or breastfeeding individuals or those with clotting disorders. In summary, Traxlink ET Tablet offers an effective solution for those experiencing excessive bleeding, combining the beneficial properties of tranexamic acid and ethamsylate. By following medical advice and using this medication responsibly, patients can achieve better health outcomes.

Store in a cool, dry place below 30°C (86°F) and away from moisture and sunlight.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Tranexamic Acid IP 100mg Injection in the PCD pharma franchise market?

Tranexamic Acid IP 100mg Injection has strong demand in the critical care, surgery, gynecology, trauma care, and hospital care segment, making it a valuable product for medical distributors, institutional suppliers, and pharma franchise partners serving hospitals and specialty healthcare facilities.

Why should medical distributors include Tranexamic Acid IP 100mg Injection in their product range?

Medical distributors and agencies can benefit from consistent demand for bleeding management under specialist medical supervision. Tranexamic Acid IP 100mg Injection is an antifibrinolytic medication used to help control and prevent excessive bleeding Commonly administered for the management of surgical bleeding, trauma-related bleeding, heavy menstrual bleeding (when injectable therapy is indicated), and other bleeding disorders, as advised by healthcare professionals Helps stabilize blood clots by preventing their premature breakdown, thereby reducing blood loss in appropriate clinical situations Injectable formulation provides rapid onset of action, making it suitable for emergency, perioperative, and hospital settings Requires administration by qualified healthcare professionals with appropriate patient monitoring Frequently utilized in operating theatres, emergency departments, intensive care units (ICUs), obstetrics and gynecology departments, and trauma care centers Widely prescribed and administered by surgeons, anesthesiologists, gynecologists, emergency medicine specialists, and critical care physicians This strengthens a comprehensive hospital care and surgical product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Tranexamic Acid IP 100mg Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers, institutional suppliers, and medical agencies benefit from consistent hospital demand, repeat procurement requirements, reliable supply chain support, specialty healthcare market opportunities, and attractive margins in the critical care and surgical segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, wholesalers, and institutional suppliers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.